Kira Pharmaceuticals is a biotechnology company developing a new generation of complement-targeted therapies to treat immune-mediated diseases
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 11/15/20 | $46,000,000 |
Qiming Venture Partners Quan Capital SinoPharm Capital | undisclosed |
